We are international

July 23, 2002 IMF Myeloma Minute
In the News:

  • Next Steps for Medicare Reform?
    The political pressures of the coming election cycle have made it virtually impossible for Congress to reach agreement on any major Medicare-related legislation.

What's New in Myeloma Research:

  • Long-Term Care After Hematopoietic-Cell Transplantation in Adults
    After successful transplantation, patients remain at risk for diseases common in the general population, as well as for health problems directly related to transplantation.
    This article can be found in the New England Journal of Medicine 2002; 347:36-42, Jul 4, 2002.
  • No pain, no gain? If you've broken a bone, choose your painkiller with care.
    Some of the new non-steroidal anti-inflammatory drugs (NSAIDs) may delay or even prevent the healing of fractures.
    This article by Danny Penman can be found in the Journal of Bone and Mineral Research (vol. 17, p 903) or in New Scientist June 2002, page 6.
  • Autologous stem cell transplantation for primary systemic amyloidosis
    High-dose melphalan with autologous blood stem cell transplantation (SCT) can reverse the disease process in selected patients with primary systemic amyloidosis (AL); however, SCT for AL remains controversial because of the treatment-related mortality in patients with cardiac and multi-system organ involvement.

Items of Interest:
  • "Return of Thalidomide"
    Thalidomide, the notorious drug which caused horrendous birth defects in the 1950s and 1960s, is close to making a comeback as an anticancer drug. Drug firm Celgene of Warren, New Jersey, has applied to European drug authorities for permission to sell thalidomide to treat multiple myeloma, a fatal cancer of the bone marrow. In clinical trials the drug performed well against the disease. It will take Europe seven months or more to reach a verdict on the drug, which will not be prescribed to pregnant women or those considering having children.
    This article is from New Scientist June 2002, page 5.

As featured in this month's issue of CURE Magazine:

Important Dates to Remember:

CancerCare Peripheral Neuropathy Teleconference
Tuesday, July 30, 2002
1:00 p.m. - 2:00 p.m. ET
This teleconference is free, but participants must register online or by calling (800) 813-HOPE.

IMF Patient & Family Seminar: Chicago, IL
August 16th and 17th

International Myeloma Foundation Multiple Myeloma Awareness Week
August 26th - September 1st

Ribbon of Hope: Making A World of Difference 12th Anniversary Gala
Washington D.C.
October 5th

IMF Patient & Family Seminar: Seattle, WA
November 8th and 9th

IMF Patient & Family Seminar: Los Angeles, CA
January 24-25, 2003

Clinical Trials:

Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Previously Untreated Multiple Myeloma.

Combination Chemotherapy With or Without Interferon alfa in Treating Patients With Previously Untreated Multiple Myeloma.

Combination Chemotherapy in Treating Patients With Multiple Myeloma.

Conditioning Therapy and Blood or Marrow Transplantation in Patients With Severe Hematologic Malignancy.

Epoetin Alfa in Patients With Multiple Myeloma and Chemotherapy Related Anemia.

Three Regimens For the Prevention of Delayed Nausea After Chemotherapy in Patients With Chemotherapy-Naive Cancer.

Exciting Opportunities:

Multiple Myeloma Quilt of Courage
All the squares for the first quilt have been sold! We are now taking orders for the second quilt. Deadline will be September 27th.

Help Us Help Others...
As a non-profit organization, the IMF is completely dependent on the support of our members. Please consider showing your support by making a tax-deductible donation today. Donations in honor of a friend or family member make great gifts and are a wonderful way to celebrate a special occasion. You can donate online or by calling the IMF at (800) 452-CURE. We sincerely thank you for your support.

View Back Issues Online...
New to the IMF Myeloma Minute? See what you've been missing by viewing previous issues online!

Tell A Friend...
The Myeloma Minute is a great way to stay abreast of the latest developments within the myeloma community. We hope you'll share this information with friends, family members and physicians and encourage them to sign up for their own copy by forwarding this message. New users can register by clicking here.

 related articles